• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medical Resources delisted

Article

Imaging services provider Medical Resources of Hackensack, NJ, was delisted last month from the NASDAQ stock exchange. Medical Resources’ common stock was delisted on April 22 when NASDAQ advised the company that it does not conform to the

Imaging services provider Medical Resources of Hackensack, NJ, was delisted last month from the NASDAQ stock exchange. Medical Resources’ common stock was delisted on April 22 when NASDAQ advised the company that it does not conform to the requirements for listing on either the NASDAQ National Market or the NASDAQ SmallCap Market. The company believes its stock may be eligible for trading on NASDAQ’s OTC Bulletin Board. Medical Resources has the right to appeal NASDAQ’s decision.

The news paints a bleak picture of the status of Medical Resources’ business. In March, the company hired investment banking firm BT Alex. Brown of New York City and announced that it would seek an acquisition partner (SCAN 3/31/99). It also reported mediocre results for 1998 (end-December), posting a net loss of $19.9 million. The company attributed the loss to charges related to doubtful accounts receivable and charges associated with the settlement of a class-action lawsuit.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.